Cellular Expression of Antiapoptotic BCL-2 Oncoprotein in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: A Children's Cancer Group Study
Fatih M. Uckun(University of Southern California), Paul S. Gaynon(University of Southern California), Zhiwen Yang(Ningxia University), Gregory H. Reaman(National Cancer Institute), Peter G. Steinherz(Memorial Sloan Kettering Cancer Center), Tamer Zeren(Memorial Sloan Kettering Cancer Center), Rauf Onur Ek(Memorial Sloan Kettering Cancer Center), Mireille Sarquis(Parker Hughes Cancer Center), James B. Nachman(University of Chicago), Harland N. Sather(Children's Oncology Group), Bruce Bostrom(Minnesota West Community & Technical College), David G. Tubergen(University of Michigan), Lisa Crotty(Memorial Sloan Kettering Cancer Center)
Cited by 75
Related Papers
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|920
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
|Journal of Clinical Oncology|2001|825
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
|Cancer Cell|2012|722
Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2000|599